Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity-Reference-Cited by-同舟云学术

Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity

Published:2023-07 Issue:3 Volume:106 Page:115948
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Dourdouna Maria-Myrto,Tatsi Elizabeth-Barbara,Syriopoulou Vasiliki,Michos Athanasios^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference31 articles.

1. Antibody responses to natural SARS-CoV-2 infection or after COVID-19 vaccination;Altawalah;Vaccines (Basel),2021

2. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals;Grifoni;Cell,2020

3. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19;Sekine;Cell,2020

4. Commercial Interferon-gamma release assay to assess the immune response to first and second doses of mRNA vaccine in previously COVID-19 infected versus uninfected individuals;Tormo;Diagn Microbiol Infect Dis,2022

5. Understanding T cell responses to COVID-19 is essential for informing public health strategies;Vardhana;Sci Immunol,2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QuantiFERON SARS-CoV-2 assay for the evaluation of cellular immunity after immunization with mRNA SARS-CoV-2 vaccines: A Systematic Review and Meta-Analysis;2024-04-30

2. Cellular Immunity of SARS-CoV-2 in the Borriana COVID-19 Cohort: A Nested Case–Control Study;Epidemiologia;2024-04-10

3. Study of the cellular and humoral immune responses to SARS-CoV-2 vaccination;Heliyon;2024-04

4. Comparative Study of T-Cell Repertoires after COVID-19 Immunization with Homologous or Heterologous Vaccine Booster;Pathogens;2024-03-27

5. Natural and hybrid immunity after SARS-CoV-2 infection in children and adolescents;Infection;2024-03-18